SHANGHAI, July 20 /PRNewswire-Asia/ -- Sundia MediTech Company, a leading pharmaceutical R&D outsourcing service company in China, announced today that the company was named as a Top 100 Fast-growth Outsourcing Service Provider. This selection was jointly sponsored by China Council for International Investment Promotion (CCIIP) and three global leading market researchers, TPI, IDC and Gartner. This ranking covers outsourcing services in IT, pharmaceutical, biotech, and all industrial fields. The list was announced at the 2nd China International Outsourcing Service Cooperation Conference.
The Top 100 outsourcing ranking was determined based on company size and growth rate, business income, and per headcount revenue. As a leading pharmaceutical R&D CRO company, Sundia is consistently focused on providing high quality CRO services to pharmaceutical and biotech company clients worldwide. Since its founding in 2004, the company’s CRO service business has been growing at a high rate. “We are very pleased and honored to be included in this list,” Commented Dr. Xiaochuan Wang, Chairman and CEO of Sundia. “It is another recognition of the effort of all of our team members.”
About Sundia MediTech
Sundia MediTech Company is a leading integrated pharmaceutical contract research organization (CRO) company based in Shanghai, China. It was founded in Shanghai in 2004 by a group of veterans of the US pharmaceutical industry to provide R&D outsourcing services to biotech and pharmaceutical companies worldwide, ranging from chemical services, medicinal chemistry, biological service, new technology platforms and services, and pharmaceutical development.
SOURCE Sundia MediTech Company
CONTACT: Ms. Li Zhao, +86-21-5109-8642 x167, or lzhao@sundia.com
